C. Dickhoff

Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature

B. D. de Mol, M. L. Handoko, L. van Heerebeek, 2020, ESC heart failure.

Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction

A. Zwinderman, R. D. de Boer, M. P. van den Berg, 2021, European heart journal.

Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.

Y. Pinto, J. Tijssen, P. Meregalli, 2014, American heart journal.

Outpatient treatment of worsening heart failure with intravenous diuretics: first results from a multicentre 2‐year experience

B. D. de Mol, J. Schroeder‐Tanka, E. Wierda, 2022, ESC heart failure.

N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.

Y. Pinto, M. Metra, S. Di Somma, 2015, Journal of cardiac failure.

Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study

A. Zwinderman, P. A. van der Zwaag, A. Houweling, 2024, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.